Bharat Biotech vaccine approved for children above 12 years, - The Sikh Times
Delhi

Bharat Biotech vaccine approved for children above 12 years,

04 Jan 21 Bharat Biotech’s anti-coronavirus vaccine ‘Covaxin’ has been approved for children above the age of 12 years by the Drugs Controller General of India (DCGI). Oxford-AstraZeneca coronavirus vaccine ‘Covishield’, manufactured by Pune-based Serum Institute of India (SII) has been approved for those above the age of 18. The DCGI had on Sunday approved Bharat Biotech’s ‘Covaxin’ and Serum’s ‘Covishield’ for emergency use in the country, paving the way for a massive inoculation drive.The permission to both the vaccines — Bharat Biotech’s Covaxin and Serum Institute’s ‘Covishield’ — has been granted for restricted use in emergency situations. Both the vaccines will be administered in two doses, the DCGi said in the permission letter.

Related posts

price of petrol remained at Rs 81.06 per liter and diesel was at Rs 70.46 per liter, unchanged On Saturday

thesikh

Delhi Crosses 7,000 Per Day COVID-19 cases in Delhi

thesikh

Delhi: Full seating capacity till November 30

thesikh

Centre-Farmer Talks Today On Repeal Of Farm Laws

thesikh

Indian Rafale fighters with air-to-surface Hammer all-weather smart weapon apart from air-to-air MICA

thesikh

No Progress At Meeting Between Police, Farmer Unions- Republic Day

thesikh

Leave a Comment